Research study explores gene therapy treatment to reduce symptoms of Parkinson's disease
Tuesday, March 8, 2011 - 13:01
in Health & Medicine
Physicians at Rush University Medical Center are testing a unique gene therapy product called CERE-120 to evaluate if its use can improve the symptoms of Parkinson's disease. Rush is one of 11 sites in the U.S. and the only site in Illinois enrolling patients into the new, double-blinded trial.